- Trials with a EudraCT protocol (256)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
		
	   		
	   		    
                    
                   	
                   	    256 result(s) found for: Case management.
                    
                
			
   			
		
		Displaying page 1 of 13.
	
	
	| EudraCT Number: 2015-003760-36 | Sponsor Protocol Number: HUS277/03/2015 | Start Date*: 2016-01-20 | 
| Sponsor Name:HUS - Naistentautien ja synnytysten tulosyksikkö | ||
| Full Title: Pain an medical abortion -Predicting factors of pain and optimal pain management among teenaged women compared to adult women | ||
| Medical condition: Pain during Medical termination of pregnancy | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-001201-10 | Sponsor Protocol Number: FEN-PPA-401 | Start Date*: 2004-07-26 | |||||||||||
| Sponsor Name:JANSSEN-CILAG | |||||||||||||
| Full Title: Comparison of transdermal fentanyl PCA and IV morphine PCA in the management of post-operative pain control. | |||||||||||||
| Medical condition: Treatment of moderate to severe post-operative pain in subjects who have undergone an elective major abdominal or orthopaedic surgical procedure. | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-000302-29 | Sponsor Protocol Number: AlbuCAT | Start Date*: 2019-07-31 | |||||||||||
| Sponsor Name:Fundació Clinic per a la Recerca Biomèdica | |||||||||||||
| Full Title: ALBUMIN FOR MANAGEMENT OF HYPERVOLEMIC HYPONATREMIA IN PATIENTS WITH DECOMPENSATED CIRRHOSIS. A PROOF OF CONCEPT STUDY | |||||||||||||
| Medical condition: HYPERVOLEMIC HYPONATREMIA IN PATIENTS WITH DECOMPENSATED CIRRHOSIS | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-022025-15 | Sponsor Protocol Number: 10-2-055 | Start Date*: 2011-02-21 | 
| Sponsor Name:MUMC | ||
| Full Title: Intradiscal Methylene Blue Injection Treatment for Chronic Discogenic Low back pain A prospective Clinical Series followed by a Randomised Placebo-Controlled Clinical Trial | ||
| Medical condition: The Randomized Clinical Trial (RCT) aims to prove the hypothesis that Intradiscal Methylene blue Injection is capable of better pain reduction than the best available treatment in patients sufferin... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-001916-44 | Sponsor Protocol Number: MiFlaPRO_2019 | Start Date*: 2020-01-28 | 
| Sponsor Name:Medical University Innsbruck, Department of Visceral, Transplant und Thoracic Surgery | ||
| Full Title: A multicenter, randomized, double blind placebo controlled trial of Micronized purified Flavonoid- Fraction (MPFF) in the management of radiation proctitis | ||
| Medical condition: Patients with radiation proctitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-004812-81 | Sponsor Protocol Number: 2019-48 | Start Date*: 2021-03-05 | 
| Sponsor Name:ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
| Full Title: Ketamine Low dOse Evaluation on morphine consumption in traumatic patient : a prospective randomized controlled double-blind study | ||
| Medical condition: Traumatism | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001667-85 | Sponsor Protocol Number: MDL_2020_10 | Start Date*: 2020-05-15 | 
| Sponsor Name:Hôpital Fondation Adolphe de Rothschild | ||
| Full Title: A randomized controlled trial evaluating the efficacy of local budesonide therapy in the management of hyposmia in COVID-19 patients without signs of severity | ||
| Medical condition: Patients with persistent hyposmia related to a SARS-CoV-2 infection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005657-12 | Sponsor Protocol Number: HUS277/03/2015 | Start Date*: 2016-01-21 | 
| Sponsor Name:HUS - Naistentautien ja synnytysten tulosyksikkö | ||
| Full Title: Pain an medical abortion -Predicting factors of pain and optimal pain management among teenaged women compared to adult women | ||
| Medical condition: Pain during Medical termination of pregnancy | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000343-26 | Sponsor Protocol Number: ULTRA12 | Start Date*: 2012-09-06 | 
| Sponsor Name:Academic Medical Center, Neurosurgery | ||
| Full Title: Ultra-early tranexamic acid after subarachnoid hemorrhage. A prospective, randomized, multicenter study. | ||
| Medical condition: subarachnoid hemorrhage | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-001039-29 | Sponsor Protocol Number: ESCAPE | Start Date*: 2020-04-01 | |||||||||||
| Sponsor Name:HELLENIC INSTITUTE FOR THE STUDY OF SEPSIS | |||||||||||||
| Full Title: EFFICIENCY IN MANAGEMENT OF ORGAN DYSFUNCTION ASSOCIATED WITH INFECTION BY THE NOVEL SARS-CoV-2 VIRUS (COVID-19) THROUGH A PERSONALIZED IMMUNOTHERAPY APPROACH: THE ESCAPE CLINICAL TRIAL | |||||||||||||
| Medical condition: Organ dysfunction by the novel SARS-Cov-2 virus | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-021792-81 | Sponsor Protocol Number: 2010-12 | Start Date*: Information not available in EudraCT | 
| Sponsor Name:ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
| Full Title: SFCE-Metro 01 : Etude de phase II de chimiothérapie métronomique associant celecoxib-methotrexate-vinblastine-cyclophosphamide chez les enfants porteurs d’une tumeur solide en rechute ou en progre... | ||
| Medical condition: children and adolescents with relapsed or progressing solid tumours. | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-005420-42 | Sponsor Protocol Number: S55983 | Start Date*: 2014-02-06 | ||||||||||||||||
| Sponsor Name:University Hospital Leuven | ||||||||||||||||||
| Full Title: Is postoperative IUI better than expectant management in infertile endometriosis patients with good prognosis based on EFI score? | ||||||||||||||||||
| Medical condition: (Sub)Fertility in endometriosis after laparoscopic removal of the endometriosos lesions: an RCT comparing intra-uterine insemination with expectant management | ||||||||||||||||||
| 
 | ||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2014-002455-26 | Sponsor Protocol Number: IRON-CMR | Start Date*: 2014-09-20 | 
| Sponsor Name:Karolinska Institute | ||
| Full Title: The use of intravenous Iron oxide as a contrast agent for cardiac magnetic resonance imaging. | ||
| Medical condition: Cardiovascular diseases: Acute myocardial infarction, chronic myocardial infarction, myocardial ischemia, myocarditis, diffuse myocardial fibrosis. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-002341-20 | Sponsor Protocol Number: PLAF1003 | Start Date*: 2008-07-10 | 
| Sponsor Name:Queen Charlotte's and Chelsea Hospital | ||
| Full Title: Randomized controlled trial comparing the effect of carbetocin vs syntocinon and ergometrine on postpartum haemorrhage in patients undergoing elective caesarean section | ||
| Medical condition: Clinical efficacy comparing ( 2 drugs) carbetocin Vs syntocinon and ergometrine | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004621-24 | Sponsor Protocol Number: V00034CR3131B | Start Date*: 2013-02-04 | |||||||||||
| Sponsor Name:PIERRE FABRE MEDICAMENT | |||||||||||||
| Full Title: Emollients in the management of atopic dermatitis in children: prevention of flares. | |||||||||||||
| Medical condition: Atopic dermatitis | |||||||||||||
| 
 | |||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: LT (Completed) EE (Completed) PL (Completed) FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-000842-79 | Sponsor Protocol Number: IJB-PROS-PROSPERO-2016 | Start Date*: 2016-09-08 | ||||||||||||||||
| Sponsor Name:Institut Jules Bordet | ||||||||||||||||||
| Full Title: Prospective evaluation of 68Ga-PSMA PET-CT for Recurrence detection of Prostate Cancer and its impact on patient management The ProsPERo Trial | ||||||||||||||||||
| Medical condition: Males 18 years of age or older with histologically-proven prostate adenocarcinoma and biochemical relapse with rising PSA level after initial treatment with radical curative intent, not yet on pall... | ||||||||||||||||||
| 
 | ||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
| Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2006-000344-10 | Sponsor Protocol Number: 06_ENDO_49 | Start Date*: 2006-06-08 | 
| Sponsor Name:Christie Hospital | ||
| Full Title: Multi-centre study of cabergoline alone and in combination with pegvisomant in the management of active acromegaly | ||
| Medical condition: acromegaly | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) IE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-002802-21 | Sponsor Protocol Number: PRIMERA001 | Start Date*: 2020-12-18 | ||||||||||||||||
| Sponsor Name:Erasmus Medical Center | ||||||||||||||||||
| Full Title: PeRsonalIzed MEdicine in Rheumatoid Arthritis (PRIMERA trial): a multicenter, single-blinded, randomized controlled trial comparing usual care with a tailor-made approach | ||||||||||||||||||
| Medical condition: Rheumatoid arthritis according to 2010 criteria | ||||||||||||||||||
| 
 | ||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2008-002031-32 | Sponsor Protocol Number: PASS-2007 | Start Date*: 2008-05-05 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA S. GERARDO DI MONZA | |||||||||||||
| Full Title: Phase III study protocol to compare conservative and active treatment during the third stage of labour in physiological childbirth | |||||||||||||
| Medical condition: THIRD STAGE OF LABOR MANAGEMENT | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-001882-36 | Sponsor Protocol Number: ACHIEVE | Start Date*: 2020-05-07 | |||||||||||
| Sponsor Name:Hellenic Institute for the Study of Sepsis | |||||||||||||
| Full Title: ANTI-INFLAMMATORY CLARITHROMYCIN TO IMPROVE SARS-CoV-2 (COVID-19) INFECTION EARLY: THE ACHIEVE OPEN-LABEL NON-RANDOMIZED CLINICAL TRIAL | |||||||||||||
| Medical condition: Management of infection by SARS-CoV-2 (COVID-19) | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
			Subscribe to this Search
To subscribe to the RSS feed for this search click here .
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		
			
To subscribe to the RSS feed for this search click here
 .
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
 Query did not match any studies.
    	Query did not match any studies.
     
				
